GLP-1 inhibitors may protect against brain degenerationStudy participants who were treated with the GLP-1 inhibitor had a lower risk of dementia, ischemic stroke and all-cause mortality. October drug roundup: two new dosage formsGet the info you need on these new dosage forms, part of our drug news roundup for October. Let's get pumping! Answers to common questions about insulin pump therapy. Building value over volume: Calgary’s Meadows Mile is proving that when care comes first, patients follow Patients who try to book with the physicians in the building—who are often scheduled months in advance—are automatically offered an appointment with a clinical pharmacist when appropriate who can prescribe within scope. Optimizing antipsychotic therapy Pharmacists can play key roles in monitoring adherence and treatment response, and managing adverse effects. OCP seeks feedback on proposed changes to medication safety program Some pharmacists objecting to cost of the reporting platform to pharmacies, as well as required continuous quality improvement meetings. Case report: Sore feet I wonder how many ‘acute care’ physicians feel comfortable with making changes in a long list of medications reported by a patient. The silent epidemic: how digital distractions are putting pharmacy safety at risk There's a frighteningly small window in which a glance away from the screen can turn a routine prescription into a preventable tragedy. New tool to help Ontario pharmacists connect patients to addiction care Free resource in Ontario will help patients find pharmacies offering opioid use disorder services. How to manage severe refractory asthma Consider a biologic when severe asthma remains uncontrolled despite an inhaled corticosteroid plus a second controller. First Previous 4 5 6 7 8 Next Last